ZAI LAB LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.91 USD | +1.08% |
|
+13.08% | -41.79% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,753 | 11,913 | 6,059 | 2,946 | 2,688 | 1,571 | - | - |
| Enterprise Value (EV) 1 | 2,484 | 10,726 | 4,650 | 1,938 | 1,897 | 1,080 | 1,296 | 1,279 |
| P/E ratio | -13.7 x | -39.1 x | -8.29 x | -6.63 x | -7.9 x | -4.86 x | -15.4 x | 8.74 x |
| Yield | - | - | - | - | - | - | 1.26% | - |
| Capitalization / Revenue | 212 x | 243 x | 42 x | 13.7 x | 10.1 x | 4.14 x | 2.47 x | 1.64 x |
| EV / Revenue | 191 x | 219 x | 32.2 x | 9.01 x | 7.11 x | 2.84 x | 2.04 x | 1.34 x |
| EV / EBITDA | -12.5 x | -36.1 x | -6.7 x | -4.89 x | -5.3 x | -3.26 x | -7.24 x | 122 x |
| EV / FCF | -12.6 x | -47.4 x | -8.19 x | -4.94 x | -9.23 x | -3.14 x | -8.49 x | 36.9 x |
| FCF Yield | -7.93% | -2.11% | -12.2% | -20.2% | -10.8% | -31.8% | -11.8% | 2.71% |
| Price to Book | 9.63 x | 10.2 x | 4.35 x | - | 3.34 x | 3.16 x | 7.5 x | 18.9 x |
| Nbr of stocks (in thousands) | 66,199 | 88,024 | 96,409 | 95,972 | 98,349 | 98,718 | - | - |
| Reference price 2 | 41.59 | 135.3 | 62.85 | 30.70 | 27.33 | 15.91 | 15.91 | 15.91 |
| Announcement Date | 3/19/20 | 3/1/21 | 3/1/22 | 3/1/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12.98 | 48.96 | 144.3 | 215 | 266.7 | 379.5 | 634.9 | 955.8 |
| EBITDA 1 | -199.4 | -297.2 | -693.6 | -396.1 | -357.5 | -331.5 | -178.9 | 10.52 |
| EBIT 1 | -203.2 | -301.8 | -700.1 | -404.4 | -366.6 | -338.1 | -152.2 | 56.06 |
| Operating Margin | -1,564.88% | -616.45% | -485.1% | -188.04% | -137.44% | -89.1% | -23.97% | 5.87% |
| Earnings before Tax (EBT) 1 | -194.3 | -267.8 | -703.4 | -443.1 | -334.6 | -319.4 | -115.5 | 100.9 |
| Net income 1 | -195.1 | -268.9 | -704.5 | -443.3 | -334.6 | -317.1 | -126.1 | 83.41 |
| Net margin | -1,502.31% | -549.26% | -488.16% | -206.14% | -125.46% | -83.56% | -19.86% | 8.73% |
| EPS 2 | -3.030 | -3.460 | -7.580 | -4.630 | -3.460 | -3.270 | -1.032 | 1.820 |
| Free Cash Flow 1 | -197 | -226.2 | -567.5 | -392.2 | -205.4 | -343.4 | -152.6 | 34.62 |
| FCF margin | -1,517.52% | -462% | -393.26% | -182.4% | -77.01% | -90.49% | -24.04% | 3.62% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 329.08% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 41.51% |
| Dividend per Share 2 | - | - | - | - | - | - | 0.2000 | - |
| Announcement Date | 3/19/20 | 3/1/21 | 3/1/22 | 3/1/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 9.565 | 19.21 | 29.74 | 57.04 | 43.1 | 44.17 | 87.27 | 46.72 | 48.18 | 94.9 | 57.54 | 62.6 | 120.1 | 62.8 | 68.86 | 69.23 | 65.83 | 75.24 | 85.46 | 99.15 | 119.8 |
| EBITDA 1 | - | - | - | - | - | -217.3 | - | -77.75 | - | - | - | - | - | - | - | - | -121.5 | -105.3 | -91.23 | -82.42 | -66.31 |
| EBIT 1 | -117.3 | -130.3 | -171.5 | -397.7 | -83.2 | -219.2 | -302.4 | -79.76 | -98.72 | -178.5 | -128.6 | -97.29 | -225.9 | -69.52 | -89.5 | -83.57 | -124 | -96.82 | -92.88 | -85.96 | -78.89 |
| Operating Margin | -1,226.58% | -678.12% | -576.61% | -697.19% | -193.04% | -496.24% | -346.5% | -170.71% | -204.91% | -188.07% | -223.47% | -155.42% | -188.01% | -110.71% | -129.97% | -120.72% | -188.34% | -128.68% | -108.68% | -86.69% | -65.86% |
| Earnings before Tax (EBT) 1 | -111.3 | -128.2 | -139.6 | - | -96.07 | -211.3 | - | -82.17 | -137.9 | - | -161.2 | -61.77 | - | -49.14 | -120.9 | -69.15 | -95.43 | -93.07 | -88.57 | -81.67 | -67.23 |
| Net income 1 | -111.8 | -128.6 | -140.3 | - | -96.41 | -211.8 | - | -82.39 | -137.9 | - | -161.2 | -61.77 | -223 | -49.14 | -120.9 | -69.15 | -95.43 | -91.7 | -87.05 | -79.05 | -66.92 |
| Net margin | -1,168.87% | -669.43% | -471.64% | - | -223.68% | -479.56% | - | -176.34% | -286.31% | - | -280.14% | -98.67% | -185.58% | -78.26% | -175.56% | -99.89% | -144.96% | -121.88% | -101.86% | -79.72% | -55.88% |
| EPS 2 | -1.660 | -1.740 | -1.720 | - | -1.010 | -2.240 | - | -0.8600 | -1.440 | - | -1.680 | -0.6500 | - | -0.5100 | -1.250 | -0.7100 | -0.9800 | -0.9391 | -0.8913 | -0.8113 | -0.6830 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/19/20 | 8/13/20 | 3/1/21 | 8/9/21 | 11/9/21 | 3/1/22 | 3/1/22 | 5/10/22 | 8/9/22 | 8/9/22 | 11/9/22 | 3/1/23 | 3/1/23 | 5/9/23 | 8/7/23 | 11/7/23 | 2/27/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 269 | 1,187 | 1,409 | 1,008 | 791 | 491 | 275 | 292 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -197 | -226 | -568 | -392 | -205 | -343 | -153 | 34.6 |
| ROE (net income / shareholders' equity) | -71.5% | -36.7% | -55.3% | -36.6% | -36.3% | -51.2% | -35.7% | -9.08% |
| ROA (Net income/ Total Assets) | -59.4% | -32.5% | -48.5% | -31.3% | -29.7% | -38.1% | -13.6% | 20.6% |
| Assets 1 | 328.6 | 826.4 | 1,454 | 1,415 | 1,128 | 831.3 | 926.3 | 405.7 |
| Book Value Per Share 2 | 4.320 | 13.30 | 14.50 | - | 8.190 | 5.030 | 2.120 | 0.8400 |
| Cash Flow per Share | -2.970 | -2.780 | -5.910 | - | - | - | - | - |
| Capex 1 | 6.04 | 10.1 | 18.3 | 24.6 | 7.21 | 17.2 | 21.6 | 30.8 |
| Capex / Sales | 46.48% | 20.69% | 12.68% | 11.43% | 2.7% | 4.53% | 3.41% | 3.22% |
| Announcement Date | 3/19/20 | 3/1/21 | 3/1/22 | 3/1/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
15.91
USD
Average target price
52.5
USD
Spread / Average Target
+230.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -41.79% | 1.57B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
- Stock Market
- Equities
- ZLAB Stock
- Financials Zai Lab Limited
